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Authors’ response
We thank Dr Champion [1] for his comments, 
especially because they gave up the opportunity 
to underscore some aspects which should be 
taken into account when managing patients with 
ST elevation myocardial infarction (STEMI) who 
require mechanical ventilation (MV).
The aim of our investigation was, as stated in 
the manuscript, to assess the clinical and progno-
stic impact of MV at short and long term mortality 
in consecutive unselected STEMI patients. The 
purpose to specifically address the clinical impli-
cations of MV in cardiogenic shock, though very 
interesting, does not belong to our study design [2].
In our center, in previous studies performed in 
cardiogenic shock (CS) following STEMI, MV was 
performed in a subset of patients with CS, that is 
in 42.9% [3] and 32.9% [4], respectively.
Indeed, a clinical diagnosis of CS was made on 
the condition that all the following criteria were pre-
sent: (1) systolic blood pressure persistently lower 
than 90 mm Hg or vasopressors required to main-
tain systolic blood pressure higher than 90 mm Hg; 
(2) signs of hypoperfusion (e.g. urine output less 
than 30 mL/h or cold/diaphoretic extremities or 
altered mental status); and (3) clinical evidence 
of elevated left ventricular filling pressure (e.g. 
pu lmonary congestion on physical examination or 
chest X-ray) [5, 6]. MV can therefore be required 
in a subset of CS patients (not in all).
In regard to MV in CS, we believe that MV 
itself is a therapy (not simply a support) and, like 
any other treatment, it should be implemented 
only when necessary and its efficacy depends also 
on the ability of physicians to use it. Generally, 
cardiologists are not often familiar with MV and are 
afraid of all the complications related to MV (i.e. 
ventilator-associated pneumonia), also because 
they are not used to prevent them.
However, the limited available clinical data on 
MV in CS suggest that a moderate level of positive 
end espiratory pressure is safe to use in severe left 
ventricular dysfunction and CS, and may provide he-
modynamic benefits as well in left ventricular failure 
which exhibits afterload-sensitive physiology [7].
We agree with Dr Champion that investigating 
the clinical impact (as well as the modalities) of 
MV in those patients with CS who require it de-
serves a clinical study specifically addressing this 
topic and possibly performed by well experienced 
cardiologists.
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